share_log

Deutsche Bank Maintains Buy on Roivant Sciences, Raises Price Target to $15

Moomoo 24/7 ·  Apr 3 05:14

Deutsche Bank analyst Neena Bitritto-Garg maintains Roivant Sciences (NASDAQ:ROIV) with a Buy and raises the price target from $14 to $15.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment